Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
J Clin Lab Anal. 2019 Nov;33(9):e22991. doi: 10.1002/jcla.22991. Epub 2019 Aug 2.
Internal quality control (IQC) in clinical laboratories is carried out to monitor analytical stability. Usually, the satisfactory results of the IQC ensure the acceptability of the examination results. Here, we reported that patients' creatinine results are unreliable, although the internal quality control is satisfactory.
Creatinine levels were analyzed from two quality control materials and twenty patients' specimens using two different lots of reagents. Lot-to-lot comparison was performed. The daily median values of serum creatinine levels of patients were calculated from the test results recorded in our laboratory information system.
Although IQC was consistent, serum creatinine concentrations were higher using lot B (median: 153 μmol/L; interquartile range: 122-522 μmol/L) than using lot A (median: 133 μmol/L; interquartile range: 76-508 μmol/L) for 20 patients (P = .001). The Deming linear regression showed a best fit of y = 0.9394 × x + 45.66. R = .8919, and mean percentage difference between two lots was 34%. The new lot was considered unacceptable. Likewise, the median serum creatinine level from the 360 patients using lot B was 102 μmol/L, which was significantly higher than the daily medians of patients using lot A (median: 66 μmol/L; range: 61-70 μmol/L) in the previous month.
The variations in creatinine concentrations proved to be due to different lots of reagents. However, IQC materials tested using both lots of reagent exhibited minimal variation. Therefore, IQC alone is insufficient for assessing laboratory analytical results. This finding prompts us to be vigilant in potential pitfall of interpreting test results based on satisfactory IQC alone.
临床实验室的内部质量控制(IQC)用于监测分析稳定性。通常,IQC 的满意结果可确保检验结果的可接受性。在这里,我们报告尽管内部质量控制令人满意,但患者的肌酐结果不可靠。
使用两种不同批次的试剂分析两种质控材料和二十名患者标本的肌酐水平。进行了批间比较。通过实验室信息系统中记录的检测结果,计算患者血清肌酐水平的每日中位数。
尽管 IQC 一致,但 20 名患者使用试剂批 B(中位数:153 μmol/L;四分位距:122-522 μmol/L)时的血清肌酐浓度高于使用试剂批 A(中位数:133 μmol/L;四分位距:76-508 μmol/L)(P =.001)。Deming 线性回归显示最佳拟合为 y = 0.9394 × x + 45.66。R ² =.8919,两个批次之间的平均差异百分比为 34%。新批次被认为不可接受。同样,使用试剂批 B 的 360 名患者的中位血清肌酐水平为 102 μmol/L,明显高于前一个月使用试剂批 A 的患者(中位数:66 μmol/L;范围:61-70 μmol/L)的每日中位数。
肌酐浓度的变化证明是由于试剂的不同批次所致。然而,两种试剂批都检测到的 IQC 材料表现出最小的变化。因此,单独的 IQC 不足以评估实验室分析结果。这一发现促使我们警惕仅基于满意的 IQC 来解释测试结果的潜在陷阱。